United Kingdom Approves AstraZeneca
🇬🇧 UK Greenlights AstraZeneca's Oxford COVID-19 Vaccine
Hey there! The UK's drugs regulatory body has given the thumbs up to the COVID-19 jab whipped up by the University of Oxford and drug giant AstraZeneca. This shindig meets the strict dossier of safety, quality, and effectiveness measures. The British government dropped this bombshell on Wednesday.
The OK could pump some serious adrenaline into the UK's vaccination drive. The British government's purse has already sourced a cool 100 million doses of this puppy—that's enough vax juices to jab 50 million people. Unlike those pricey mRNA vaccines, AstraZeneca's brew doesn't demand freezer temperatures from the coldest parts of Antarctica!
So, the efficacy of this vaccine? Well, it varies from 62% to 90%. A bit of a rollercoaster, ain't it?
[📸 Discarded face mask in autumn, via dts News Agency]
Say, wanna share or email this juicy tidbit?
What we think you should know:
This Oxford-AstraZeneca vaccine, also known by its name ChAdOx1-S, is a viral vector vaccineusing a weakened chimpanzee adenovirus to deliver the SARS-CoV-2 virus bits to help our immune system recognize and fight the coronavirus.
- Against Symptomatic Disease: Studies suggest that after two doses, it's about 85% effective in preventing COVID-19 symptoms.
- Vaccine Effectiveness Over Time: Interestingly, the effectiveness leaps significantly after the second dose, to approximately 89%.
Additionally:
- Cost and Accessibility: This vaccine is more affordable than the mRNA vaccines, making it more accessible to a global population.
- Distribution: It can be stored in your typical refrigerator (2°C to 8°C), making transportation a breeze compared to the mRNA vaccines.
- Manufacturing Capacity: AstraZeneca has a massive production capacity, which is a game-changer in addressing the global demand.
On a more complicated note:
- Efficacy Against Variants: This vaccine has faced challenges in terms of efficacy against certain variants like the 🇧🇷 P.1. However, it still provides some protection against these critters.
Overall, this vaccine is a vital weapon in the COVID-19 battle, particularly in regions with financial and distribution obstacles. So, keep those mask-wearing habits, folks, and remember to get your jab when it's available! 💪🏽💉🚀
Other science breakthroughs in health-and-wellness sectors could benefit from the UK's regulatory approval process, following the greenlight for Oxford-AstraZeneca's COVID-19 vaccine. The efficacy of this viral vector vaccine, named ChAdOx1-S, varies from 62% to 90%, with studies indicating it's about 85% effective after two doses and significantly increases to approximately 89% effectiveness after the second dose.
